This Article Full Text Full Text (PDF) Supplemental Research Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, Y. Articles by Wang, Y. Search for Related Content PubMed PubMed Citation Articles by Wu, Y. Articles by Wang, Y. Social Bookmarking                   What's this?

LETTER

Data-Mining Approaches Reveal Hidden Families of Proteases in the Genome of Malaria Parasite

¹Department of Protistology, American Type Culture Collection, Manassas, Virginia 20110, USA; ²EST Informatics, Astrazeneca Pharmaceuticals, Wilmington, Delaware 19810, USA;³ Department of Bioinformatics, American Type Culture Collection, Manassas, Virginia 20110, USA

The search for novel antimalarial drug targets is urgent due to the growing resistance of Plasmodium falciparum parasites to available drugs. Proteases are attractive antimalarial targets because of their indispensable roles in parasite infection and development, especially in the processes of host erythrocyte rupture/invasion and hemoglobin degradation. However, to date, only a small number of proteases have been identified and characterized in Plasmodium species. Using an extensive sequence similarity search, we have identified 92 putative proteases in the P. falciparum genome. A set of putative proteases including calpain, metacaspase, and signal peptidase I have been implicated to be central mediators for essential parasitic activity and distantly related to the vertebrate host. Moreover, of the 92, at least 88 have been demonstrated to code for gene products at the transcriptional levels, based upon the microarray and RT-PCR results, and the publicly available microarray and proteomics data. The present study represents an initial effort to identify a set of expressed, active, and essential proteases as targets for inhibitor-based drug design.

[Supplemental material is available online at www.genome.org.]

⁵ Corresponding author.

E-MAIL ywang{at}atcc.org; FAX (703) 365-2740.

Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.913403.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Lisk, M. Pain, I. Y. Gluzman, S. Kambhampati, T. Furuya, X.-z. Su, M. P. Fay, D. E. Goldberg, and S. A. Desai Changes in the Plasmodial Surface Anion Channel Reduce Leupeptin Uptake and Can Confer Drug Resistance in Plasmodium falciparum-Infected Erythrocytes Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2346 - 2354. [Abstract] [Full Text] [PDF]

				S. Dalal and M. Klemba Roles for Two Aminopeptidases in Vacuolar Hemoglobin Catabolism in Plasmodium falciparum J. Biol. Chem., December 7, 2007; 282(49): 35978 - 35987. [Abstract] [Full Text] [PDF]

				J. E. McCoubrie, S. K. Miller, T. Sargeant, R. T. Good, A. N. Hodder, T. P. Speed, T. F. de Koning-Ward, and B. S. Crabb Evidence for a Common Role for the Serine-Type Plasmodium falciparum Serine Repeat Antigen Proteases: Implications for Vaccine and Drug Design Infect. Immun., December 1, 2007; 75(12): 5565 - 5574. [Abstract] [Full Text] [PDF]

				E. L. Ponder and M. Bogyo Ubiquitin-Like Modifiers and Their Deconjugating Enzymes in Medically Important Parasitic Protozoa Eukaryot. Cell, November 1, 2007; 6(11): 1943 - 1952. [Full Text] [PDF]

				A. Kumar, K. Kumar, R. Korde, S. K. Puri, P. Malhotra, and V. Singh Chauhan Falcipain-1, a Plasmodium falciparum Cysteine Protease with Vaccine Potential Infect. Immun., April 1, 2007; 75(4): 2026 - 2034. [Abstract] [Full Text] [PDF]

				S. Parikh, J. Liu, P. Sijwali, J. Gut, D. E. Goldberg, and P. J. Rosenthal Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2207 - 2209. [Abstract] [Full Text] [PDF]

				Y. M. Kim, M. H. Lee, T. G. Piao, J. W. Lee, J. H. Kim, S. Lee, K. M. Choi, J. H. Jiang, T. U. Kim, and H. Park Prodomain Processing of Recombinant Plasmepsin II and IV, the Aspartic Proteases of Plasmodium falciparum, Is Auto- and Trans-Catalytic J. Biochem., February 1, 2006; 139(2): 189 - 195. [Abstract] [Full Text] [PDF]

				K. C. Pandey, S. X. Wang, P. S. Sijwali, A. L. Lau, J. H. McKerrow, and P. J. Rosenthal The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif PNAS, June 28, 2005; 102(26): 9138 - 9143. [Abstract] [Full Text] [PDF]

				A. Coppi, C. Pinzon-Ortiz, C. Hutter, and P. Sinnis The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion J. Exp. Med., January 3, 2005; 201(1): 27 - 33. [Abstract] [Full Text] [PDF]

				M. Klemba, I. Gluzman, and D. E. Goldberg A Plasmodium falciparum Dipeptidyl Aminopeptidase I Participates in Vacuolar Hemoglobin Degradation J. Biol. Chem., October 8, 2004; 279(41): 43000 - 43007. [Abstract] [Full Text] [PDF]

				P. S. Sijwali, K. Kato, K. B. Seydel, J. Gut, J. Lehman, M. Klemba, D. E. Goldberg, L. H. Miller, and P. J. Rosenthal Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites PNAS, June 8, 2004; 101(23): 8721 - 8726. [Abstract] [Full Text] [PDF]

				X. S. Puente and C. Lopez-Otin A Genomic Analysis of Rat Proteases and Protease Inhibitors Genome Res., April 1, 2004; 14(4): 609 - 622. [Abstract] [Full Text] [PDF]

				A. N. Hodder, D. R. Drew, V. C. Epa, M. Delorenzi, R. Bourgon, S. K. Miller, R. L. Moritz, D. F. Frecklington, R. J. Simpson, T. P. Speed, et al. Enzymic, Phylogenetic, and Structural Characterization of the Unusual Papain-like Protease Domain of Plasmodium falciparum SERA5 J. Biol. Chem., November 28, 2003; 278(48): 48169 - 48177. [Abstract] [Full Text] [PDF]